More tools:Markets·Screener·Research·Chat

Alpha Tau Medical Ltd. Ordinary Shares (DRTS) Financial Statements

Alpha Tau Medical Ltd. Ordinary Shares
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00H5XSKC6
XNAS · usd
14.84▼ 0.19 (-1.26%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close15.03
Day's Range14.47 – 15.08
52-Week Range3.43 – 15.17
Volume555.7K
Avg Volume598.9K
Share Statistics
Shares Outstanding
Employees121
ExchangeXNAS
Listed2022-03-08
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Alpha Tau Medical Ltd. Ordinary Shares (DRTS)
What is Alpha Tau Medical Ltd. Ordinary Shares's Market Cap?
Alpha Tau Medical Ltd. Ordinary Shares's Market Cap is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Alpha Tau Medical Ltd. Ordinary Shares's Enterprise Value?
Alpha Tau Medical Ltd. Ordinary Shares's Enterprise Value is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Alpha Tau Medical Ltd. Ordinary Shares's EV / EBITDA?
Alpha Tau Medical Ltd. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Alpha Tau Medical Ltd. Ordinary Shares's Net Income (TTM)?
Alpha Tau Medical Ltd. Ordinary Shares's Net Income (TTM) is -$42.6M, based on as-reported figures from SEC (XBRL) filings.
What is Alpha Tau Medical Ltd. Ordinary Shares's EBITDA?
Alpha Tau Medical Ltd. Ordinary Shares's EBITDA is -$41.1M, based on as-reported figures from SEC (XBRL) filings.
What is Alpha Tau Medical Ltd. Ordinary Shares's Diluted EPS (TTM)?
Alpha Tau Medical Ltd. Ordinary Shares's Diluted EPS (TTM) is -0.48, based on as-reported figures from SEC (XBRL) filings.
What is Alpha Tau Medical Ltd. Ordinary Shares's Net Debt?
Alpha Tau Medical Ltd. Ordinary Shares's Net Debt is -$73.1M, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Research and development, net
Marketing expenses
General and administrative
Total operating loss
Financial (income) expenses, net
Loss before taxes on income
Tax on income
Net loss
Net loss per share, basic (in Dollars per share)
Net loss per share, diluted (in Dollars per share)